Profil
Bob Yant is the founder of Cure Medical LLC and Axonis Therapeutics, Inc. At Cure Medical LLC, he held no specific title.
At Axonis Therapeutics, Inc., he held the titles of President and Director, but is no longer active in those roles.
Postes actifs de Bob Yant
Sociétés | Poste | Début |
---|---|---|
Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation. | Fondateur | - |
Anciens postes connus de Bob Yant
Sociétés | Poste | Fin |
---|---|---|
Cure Medical LLC
Cure Medical LLC Medical SpecialtiesHealth Technology Cure Medical LLC manufactures medical supplies. Its products include Cure Catheter, Cure Dextra, Cure Medical, Cure Twist, and Cure Ultra. The company was founded by Bob Yant in 2007 and is headquartered in Newport Beach, CA. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
Cure Medical LLC
Cure Medical LLC Medical SpecialtiesHealth Technology Cure Medical LLC manufactures medical supplies. Its products include Cure Catheter, Cure Dextra, Cure Medical, Cure Twist, and Cure Ultra. The company was founded by Bob Yant in 2007 and is headquartered in Newport Beach, CA. | Health Technology |
Axonis Therapeutics, Inc.
Axonis Therapeutics, Inc. Medical/Nursing ServicesHealth Services Axonis Therapeutics, Inc. is a biotechnology company based in Cambridge, MA, committed to developing groundbreaking therapies for spinal cord injury and other currently incurable neurological disorders. The company is advancing two breakthrough discoveries, KCC2 upmodulation to reactivate spared tissue and PTEN inhibition to regenerate injured nerve connections, to make a real difference for patients, their families, and the healthcare system. The company was founded by Lisa McKerracher, Corey S. Goodman, Oswald Steward, Joanna Stanicka, Patrick J. Carew, Shane V. Hegarty, Bob Yant. Joanna Stanicka has been the CEO since incorporation. | Health Services |